Lucrative pharma jobs leave FDA with hundreds of vacancies
The FDA has more than 700 job vacancies in its division that reviews new drugs, and the agency has been under fire for taking too long to approve medications.
FDA new drug approvals drop in 2013 but include first 3 ‘breakthrough’ therapies
Following a 15-year high in 2012, new FDA drug approvals were down last year. Among the 27 new drugs approved in 2013 were eight new cancer therapies, three diagnostic imaging agents and three medicines that received expedited review under the FDA’s new “breakthrough therapy” designation program. That’s about on par with the average over the […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.